Released: ·Last reviewed: ·Prices re-read October 15, 2026 (rows marked)·Methodology v4.1
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.
All provider reviews
Every GLP-1 telehealth provider we track, with advertised pricing and current verification status.
Quick answer
We track 19 GLP-1 telehealth providers. Each entry shows advertised price and our current verification status: Verified documented, Reported — pending verification reported and pending capture, Evaluation in progress evaluation in progress. We publish nothing as confirmed until our research team verifies it.
| Provider | Starting price | Commitment | Data status |
|---|---|---|---|
| NexLife | $139/mo (tirzepatide, 12-month plan) | 12-month or month-to-month | Verified |
| Found | $239 per 28 days (12-month plan), read Oct 15 | 12-month prepay for the headline rate | Reported — pending verification |
| Oak Longevity | $119 semaglutide; $185 tirzepatide (12-month plans), read Oct 15 | Multi-month plan for headline rate | Reported — pending verification |
| Enhance.MD | $169/mo microdose tirzepatide; $212 semaglutide, read Oct 15 | 12-month for best rate | Reported — pending verification |
| Mochi Health | No compounded price printed on Oct 15 | Monthly; commitment tiers reduce membership | Reported — pending verification |
| Shed | $149/mo semaglutide microdose; $239 tirzepatide (12-month), read Oct 15 | 2-month minimum | Reported — pending verification |
| TrimRx | $199 first month, then $299 semaglutide, read Oct 15 | Prepay tiers no longer printed (Oct 15) | Reported — pending verification |
| Henry Meds | “Starts at $179/month” for any GLP-1 (Oct 15) | Paid-in-full plans cut the rate sharply | Reported — pending verification |
| Noom Med | $179/mo microdose (12-week subscription), read Oct 15 | Billed quarterly | Reported — pending verification |
| Eden | $99 semaglutide; $129 tirzepatide, every month, read Oct 15 | Monthly | Reported — pending verification |
| MEDVi | Not used: its pages print conflicting prices (Oct 15) | Monthly | Reported — pending verification |
| bmiMD | $289/mo semaglutide (July; site blocked a re-read) | Monthly | Reported — pending verification |
| LillyDirect | $149/mo Foundayo 0.8 mg (archived Sep 25); Zepbound from $299, read Oct 15 | No commitment | Verified |
| NovoCare Pharmacy | $149/mo Wegovy pill 1.5 mg ($199 at 4 mg), read Oct 15 | No commitment | Verified |
| PlushCare | $299 Zepbound 2.5 mg + $19.99 membership; $129 first visit, read Oct 15 | Monthly | Reported — pending verification |
| WeightWatchers Clinic | $74/mo membership on a 12-month plan; medication billed separately, read Oct 15 | 12-month medication option | Reported — pending verification |
| Hims | $298/mo total, oral Wegovy (July; site blocked a re-read) | Monthly | Reported — pending verification |
| Hers | $298/mo total, oral Wegovy (July; site blocked a re-read) | Monthly | Reported — pending verification |
| Ro | $348/mo total, Wegovy (July; site blocked a re-read) | Monthly; annual prepay saves | Reported — pending verification |
Start with our best GLP-1 programs ranking or the most affordable compounded tirzepatide guide.
How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.